The rest of this guide explains what HDL is, what typical and optimal ranges look like, what high and low results may reflect, and what is and is not known about pushing the number up.
HDL cholesterol is the amount of cholesterol carried inside high-density lipoprotein particles, the smallest and densest of the particles that move fat through the bloodstream.
The liver and intestine release apolipoprotein A-I, the main structural protein of HDL. That protein picks up phospholipid and free cholesterol from cells, including the cholesterol-loaded macrophages that accumulate in artery walls. An enzyme called LCAT converts the free cholesterol into cholesteryl ester, the particle fills out into a mature sphere, and much of that cholesterol is eventually returned to the liver for disposal in bile. This loop is known as reverse cholesterol transport, and it is the main reason HDL earned its reputation as the helpful lipoprotein.
A standard lipid panel reports only the mass of cholesterol sitting inside those particles. It does not report how many HDL particles you have, how much apolipoprotein A-I they carry, or how well they actually pull cholesterol out of cells. Research has looked at the HDL cholesterol to apolipoprotein A-I ratio as a way of describing particle quality rather than quantity[1], and at cholesterol efflux capacity, a laboratory measure of how effectively a person's HDL accepts cholesterol from cells, which appears to track cardiovascular risk independently of the HDL number itself[2]. In plain terms, the value on your report is a rough proxy for a system, not a direct read of how well that system works.
Related: Cholesterol to HDL Ratio Calculator, Explained
Lower HDL cholesterol tends to go with higher cardiovascular risk across populations, which is why it sits on almost every lipid panel and inside most risk calculators.
The association has been studied for decades alongside LDL cholesterol and triglycerides, with long debate about which of the three carries the most weight in people with metabolic disease[3]. HDL was proposed as a prevention target in its own right on the strength of that epidemiology[4]. The complication is that association is not the same as causation. A low HDL result very often travels with high triglycerides, central body fat, insulin resistance, smoking and low activity, and each of those independently raises risk.
HDL has also been examined outside cardiology. Reviews describe associations between HDL cholesterol and non-cardiovascular conditions including infection, kidney disease, liver disease and some cancers, largely because HDL particles participate in immune signalling and inflammation as well as lipid transport[5].
The practical reading is this. A low HDL result is a useful signal that something upstream deserves attention, usually body composition, activity, insulin handling or inflammation. It is not a diagnosis, and a single number should never be interpreted alone. What it tells you is where to look next.
Most laboratories report HDL cholesterol as normal somewhere above the low forties in mg/dL, with the exact cut-off varying by lab and by sex.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| HDL cholesterol, adults | 40 to 100 mg/dL | 55 to 70 mg/dL |
| HDL cholesterol, men | 40 to 100 mg/dL | 55 to 70 mg/dL |
| HDL cholesterol, women | 50 to 100 mg/dL | 60 to 80 mg/dL |
Reference ranges vary by laboratory, assay, age and sex, so always read your result against the range printed on your own report. FitScript's optimal ranges are optimization targets rather than diagnostic cut-offs, and a result outside them is not a disease label.
Two details are worth holding onto. First, women generally run higher HDL than men from puberty onward, largely an oestrogen effect, so the same number carries different weight depending on who is being tested. Second, the gap between a standard reference range and an optimization target is deliberate. A reference range describes where most of a reference population falls. An optimization target describes where a number tends to sit in people whose wider metabolic picture looks healthy. Being inside the lab range but under the optimal band is a reason to look at the rest of the panel, not a reason for alarm, and it is worth discussing with a clinician alongside your other lipids.
A low HDL result most often reflects the metabolic pattern around it rather than a problem with HDL itself.
The common contributors are familiar. Excess visceral fat, insulin resistance, high triglycerides, a sedentary routine, smoking, poorly controlled type 2 diabetes, chronic kidney or liver disease, and certain medications. Genetic variation matters too, and a minority of people carry inherited differences in apolipoprotein A-I, ABCA1 or LCAT that produce persistently low values from a young age regardless of lifestyle. Clinical reviews of low HDL cholesterol group these causes into primary genetic forms and far more common secondary forms driven by metabolic and lifestyle factors[6].
Inflammation deserves a separate mention. During infection, injury or chronic inflammatory disease, HDL particles are remodelled and their ability to accept cholesterol from cells falls, so both the number and the function can drop for reasons that have nothing to do with diet[7]. A result taken during or shortly after an acute illness is not a good baseline.
So the sequence is observation, then meaning, then next step. The observation is a number below the range on your report. The likely meaning, given how commonly it clusters with triglycerides and central adiposity, is that the metabolic picture needs a look. The next step is a full panel read in context with a clinician, not a supplement bought on the strength of one line.
Yes, very high HDL cholesterol is not automatically better, and the assumption that more is always safer has not held up.
Several analyses have described a U-shaped or J-shaped relationship, in which both low and unusually high HDL values are associated with worse outcomes than mid-range values. Reviews of this question conclude that a high HDL cholesterol level is not always beneficial, particularly at the extreme upper end, and that the functional quality of the particles appears to matter more than their cholesterol content[8]. Dysfunctional HDL, altered by inflammation or oxidation, can lose its protective behaviour while still registering as a high number on a panel.
Very high values can also have identifiable drivers. Some are genetic, such as CETP deficiency. Others are acquired, including heavy alcohol intake, certain hormone exposures and some liver conditions. A markedly elevated result is suboptimal rather than reassuring, and it is worth discussing with a clinician who can look at the rest of the panel, your history and your alcohol intake before deciding whether anything needs to change.
For most people this is a secondary concern. Far more readers are looking at a result in the thirties or low forties than one in the hundreds.
Start by measuring the full lipid picture, then work on the two or three drivers with the largest effect rather than chasing the HDL value in isolation.
A workable sequence looks like this.
Nothing in that list is dramatic, which is precisely why it works. HDL responds to sustained change in the metabolic environment, not to short bursts of effort.
Regular exercise is the single most reliably studied non-drug way to raise HDL cholesterol, though the size of the change is usually modest.
The mechanism is reasonably well described. Endurance activity increases lipoprotein lipase activity in muscle, which clears triglyceride-rich particles from the circulation. As those particles are cleared, less cholesteryl ester is traded away from HDL in exchange for triglyceride, so more cholesterol stays inside HDL particles and the measured value rises. The same process pulls triglycerides down, which is why HDL and triglycerides so often move in opposite directions on a report.
Total weekly volume appears to matter more than intensity for this particular marker, although both help. Steady aerobic work such as brisk walking, cycling, rowing or running accumulated across most days of the week is the backbone. Resistance training contributes mainly through its effect on body composition and insulin sensitivity, and it protects muscle mass during any weight loss, which keeps the metabolic benefit intact.
Two honest caveats. First, the HDL response to training varies widely between individuals, partly for genetic reasons, so two people doing identical programmes can get different results. Second, a single hard session can transiently change lipid values, so testing the morning after an unusually long workout is not a fair reading. Keep the week before a blood draw typical rather than exceptional.
The dietary pattern that raises HDL most reliably replaces refined carbohydrate and industrial trans fat with unsaturated fat and fibre, rather than simply adding more fat on top of the existing diet.
Several specific levers are worth knowing. Industrially produced trans fat lowers HDL while raising LDL, so removing it is unambiguously useful. Monounsaturated sources such as olive oil, avocado and nuts, and omega-3 rich oily fish, are associated with higher HDL and lower triglycerides when they displace refined starch and sugar. Very low fat, high carbohydrate diets tend to lower HDL and raise triglycerides, which is one reason a blanket low-fat approach often looks worse on a lipid panel than a Mediterranean-style one. Soluble fibre from oats, legumes, barley and fruit mainly lowers LDL, but it improves the overall picture that HDL sits inside. Lower-carbohydrate approaches often raise HDL noticeably, largely through triglyceride reduction and fat loss.
Alcohol is the awkward case. Moderate intake tends to go with higher HDL cholesterol, and heavier intake can push the value high. That association has not translated into a recommendation to drink, because alcohol carries its own risks for the liver, blood pressure, sleep and cancer. Raising a lipid marker by a route that damages other systems is not an improvement in health, and no clinician recommends starting or increasing alcohol for lipid reasons.
Yes, and for most people with a low result this is the dominant factor.
Insulin resistance increases the flow of free fatty acids to the liver, which raises production of triglyceride-rich VLDL particles. Cholesteryl ester transfer protein then swaps cholesteryl ester out of HDL in exchange for triglyceride from those VLDL particles. The triglyceride-enriched HDL that results is cleared from the circulation faster, so the measured HDL cholesterol falls. This is why high triglycerides and low HDL appear together so often that the pair is treated as a signature of insulin resistance, and why the question of which lipid is the real culprit in metabolic disease has been debated for so long[3].
The practical consequence is encouraging. Fat loss, particularly visceral fat loss, tends to improve both ends of that axis at once. Triglycerides usually fall first and fastest, with HDL drifting upward more slowly over months. Improving sleep, reducing alcohol and increasing daily movement all feed into the same mechanism.
Where obesity is involved, medically supervised weight management is a legitimate route, and prescription options including GLP-1 based therapy exist. A licensed provider evaluates whether any such treatment is appropriate for a given person after reviewing their history, medications and labs. The lipid changes seen with significant weight loss follow the weight loss itself rather than acting on HDL directly.
Smoking lowers HDL cholesterol and impairs HDL function, and stopping is associated with a measurable rise, which makes it one of the few interventions that improves both the number and the underlying biology.
Tobacco smoke modifies HDL particles through oxidation and reduces their capacity to accept cholesterol from cells. Inflammation does something similar. Reviews of cholesterol efflux describe how inflammatory states remodel HDL, impairing its function even when the cholesterol content looks acceptable on paper[7]. That is worth remembering if you have an inflammatory condition, an active infection or a recent injury when your blood is drawn.
Sleep and stress act less directly but still count. Short or fragmented sleep worsens insulin sensitivity and appetite regulation, which pushes the triglyceride and HDL axis in the wrong direction over time. Sustained psychological stress raises cortisol output, which influences fat distribution and glucose handling. Neither is going to transform a lipid panel on its own, but both make every other intervention harder to sustain.
The next step here is simple to state and hard to do. If you smoke, stopping is the highest-value change available, and a clinician can discuss the support options that suit you. If sleep is consistently short, treat that as a metabolic variable rather than a lifestyle preference.
Several commonly prescribed drugs and hormone therapies move HDL cholesterol in one direction or the other, which is why a medication review belongs in any serious look at this marker.
Studies of individual statins have examined this effect specifically, including work on pitavastatin and HDL cholesterol[9].
On the hormone side, oestrogen generally raises HDL, while androgens tend to lower it. Testosterone therapy is associated with a reduction in HDL cholesterol in many people, and non-prescribed anabolic steroid use can suppress it markedly.
None of that means a medication should be stopped or started on the basis of an HDL reading, and no dose or regimen belongs in an article. A licensed provider evaluates whether any prescription therapy, including hormone therapy, is appropriate for a particular person, and whether a lipid change observed on treatment is clinically meaningful in the context of the rest of their risk profile.
Not necessarily, and this is the most important nuance on the page.
The idea that pharmacologically raising HDL would reduce cardiovascular events was tested directly. Drugs that inhibit cholesteryl ester transfer protein produced large increases in HDL cholesterol, yet the outcome trials did not deliver the expected benefit, and some were halted early.[10] Critical reviews of the HDL hypothesis have worked through why, concluding that raising the cholesterol content of HDL particles is not the same as improving reverse cholesterol transport[10]. Genetic studies pointed the same way, finding that variants associated with higher HDL did not reliably associate with lower cardiovascular risk, which is a strong argument against a simple causal relationship[4].
This is why clinical attention has shifted towards the atherogenic particles. Non-HDL cholesterol, which is total cholesterol minus HDL and therefore captures every cholesterol-carrying particle that can deposit in an artery wall, has been advocated as a therapeutic goal[11], and the relative merits of non-HDL cholesterol versus apolipoprotein B as the preferred target have been debated in detail[12].
The reasonable position is that HDL is a valuable marker and a poor target. Improving it through exercise, fat loss and stopping smoking is worth doing because those actions improve risk broadly. Improving it through a mechanism that touches nothing else may change the number without changing the outcome.
HDL cholesterol is measured directly from a blood sample as part of a standard lipid panel, usually alongside total cholesterol, triglycerides and a calculated or directly measured LDL value.
Fasting is no longer required for every lipid panel, since HDL and total cholesterol change little with a recent meal. Triglycerides do change, and calculated LDL depends on triglycerides, so many clinicians still ask for a fasting sample when the full panel matters. Follow the instruction your own laboratory or clinician gives rather than a general rule from an article.
A few preparation points improve the signal. Keep the week before the draw typical for your routine and alcohol intake. Avoid testing during or just after an acute illness, since inflammation alters lipid values. Stay in the same posture for a few minutes before the sample is taken, because prolonged standing can concentrate the sample slightly. If you are tracking change over time, try to test at a similar time of day and at the same laboratory, since assays differ.
Biological variation means a single reading is a snapshot. A membership like FitScript's, built around 150+ biomarkers tested per year with interpretation by Atlas, FitScript's AI health advisor, exists to read a marker like this against a trend and against the rest of the panel rather than in isolation.
HDL is most informative when read as part of a group, because its meaning depends almost entirely on what the surrounding numbers are doing.
The companions worth having on the same report include the following.
Reading these together turns a single ambiguous line into a picture with a direction, and that picture is what a clinician can actually act on.
Bring any lipid result to a clinician if it sits outside your laboratory's reference range, if it has changed substantially from your previous test, or if you have a family history of early cardiovascular disease.
Some situations deserve prompt attention rather than a wait-and-see approach. A very low HDL combined with markedly high triglycerides, a lipid pattern that appeared suddenly without an obvious explanation, results alongside symptoms such as chest discomfort or breathlessness, or an abnormal panel in someone with diabetes or known kidney or liver disease. These are worth discussing with a clinician promptly, and an abnormal result should never simply be ignored.
This article is educational and is not medical advice. Discuss your own results, and any treatment decision that follows from them, with a clinician or licensed provider who can see your full history.
If you want to read further on the individual markers, FitScript publishes biomarker pages on HDL Cholesterol, ldl cholesterol, total cholesterol, apolipoprotein a 1 and the ldl hdl ratio, along with a Heart Health panel overview that shows how these values are grouped and read together.
Raise it through sustained aerobic and resistance training, loss of excess body fat, stopping smoking, and replacing refined carbohydrate and trans fat with unsaturated fat and fibre. Changes are gradual and usually modest, and triglycerides often fall before HDL rises. Review any medication that affects lipids with a licensed provider.
Work on the drivers underneath it rather than the number itself. Weekly exercise volume, visceral fat reduction and insulin sensitivity have the largest effect, because HDL falls when triglyceride-rich particles accumulate. Alcohol raises HDL but is never recommended as a strategy. Retest the full panel after several months, not weeks.
Consistency beats intensity here. Accumulate aerobic activity on most days, add resistance training to protect muscle during fat loss, eliminate industrial trans fat, and shift dietary fat towards olive oil, nuts, avocado and oily fish. Stopping smoking improves both the measured value and how well HDL particles actually function.
There is no single food or supplement that reliably increases it. The pattern that works combines training, fat loss, smoking cessation and a diet lower in refined carbohydrate. Some prescription medicines also shift HDL, but a licensed provider decides whether any treatment is appropriate after reviewing your history and full lipid panel.
HDL is high-density lipoprotein, the particle that collects cholesterol from cells, including artery walls, and returns it to the liver for disposal. It earned the 'good' label from that role. Your panel reports the cholesterol inside those particles, which is only a rough proxy for how well the system works.
Target the metabolic picture around it. Regular exercise increases enzyme activity that clears triglyceride-rich particles, which leaves more cholesterol inside HDL. Fat loss and better insulin sensitivity do the same thing from another angle. Expect months rather than weeks, and read HDL alongside triglycerides and non-HDL cholesterol.
Lipid markers respond over months rather than days. Triglycerides usually move first with diet and weight change, while HDL drifts upward more slowly as body composition and insulin sensitivity improve. Retesting too early often shows normal biological variation rather than real progress, so allow a meaningful interval between panels.
Supplements are not established as a meaningful way to raise HDL, and raising the number alone has not reliably reduced cardiovascular risk. Omega-3 intake mainly lowers triglycerides. Prescription agents that affect HDL exist, but a licensed provider evaluates whether any of them is appropriate for your situation and risk profile.